Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| D604 | D604_C2 | Burkina Faso | 2006 | HIV1 | CRF02_AG | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | 3TC+AZT+NVP | NA |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| T12I, I13V, K14R, G17E, K20I, E35N, M36I, R41K, I62V, L63S, H69K, T74S, L89M |
| >D604_C2| codons 1-99 PQITLWQRPLVIVRIGEQLIEALLDTGADDTVLENINLPGKWKPKMIGGIGGFIKVRQYD QVSIEICGKKAIGSVLVGPTPVNIIGRNMLTQIGCTLNF |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| D67N, K70R, M184V, T215F | K219E | K103N, G190A | E28K, K32E, V35T, V60I, K122E, I135T, K173T, Q174K, D177E, T200A, Q207E, R211K, V245Q, D250E, T286A, I293V, S322T, D324E, I326V, G335D, A355S, R356K, M357K, G359S, A371V, I375V, T377Q, K390R, K395R, E396D, E413D, E432D, V466I, T470P, D471E, Q480H, L491S, Q509H, K512R, S519N, I522L, Q524K, K527E, E529D, A534S |
| >D604_C2| codons 1-539 PISPIETVPVKLKPGMDGPKVKQWPLTKEKIEALTEICTEMEKEGKISKIGPENPYNTPI FAIKKKNSTRWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKNKSVTVLDVGDAYFSVPL DEDFRKYTAFTIPSTNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRTKNPEIVI YQYVDDLYVASDLEIGQHRAKIEELREHLLKWGFFTPDEKHQKEPPFLWMGYELHPDKWT VQPIQLPEKESWTVNDIQKLVGKLNWASQIYAGIKVKQLCKLLRGAKALTEVVPLTEEAE LELAENREILKEPVHGVYYDPTKELVAEIQKQGQDQWTYQIYQEPFKNLKTGKYSKKRSA HTNDVKQLTEVVQKVAQESIVIWGKTPKFRLPIQRDTWEAWWTEYWQATWIPDWEFVNTP PLVKLWYQLEKDPIVGAETFYVDGAANRETKLGKAGYVTDRGRQKIVSLPETTNQKTELH AIHLALQDSGSEVNIVTDSQYALGIIQAHPDRSESELVNQILEKLIEKDKVYLSWVPAH |
References
| Author | Title | Citation |
| Sylla, M | Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso. | Antivir Ther, 2008 |